We compared descriptive, psychopathological, and treatment characteristics in a sample of 1377 consenting, closely and repeatedly evaluated adult BD patient-subjects from a specialty clinic, using bivariate methods and logistic multivariable modeling.
RESULTS: Factors found more among BD-2 > BD-1 cases included: [a] descriptors (more familial
affective disorder, older at onset, diagnosis and first-treatment, more education, employment and higher socioeconomic status, more marriage and children, and less
obesity); [b] morbidity (more general medical diagnoses, less
drug abuse and smoking, more initial depression and less [hypo]
mania or
psychosis, longer episodes, higher intake depression and anxiety ratings, less mood-switching with
antidepressants, less seasonal mood-change, greater %-time depressed and less [hypo]manic, fewer hospitalizations, more depression-predominant polarity, DMI > MDI course-pattern, and less violent suicidal behavior); [c] specific item-scores with initial HDRS21 (higher scores for depression, guilt, suicidality,
insomnia, anxiety, agitation, gastrointestinal symptoms,
hypochondriasis and
weight-loss, with less psychomotor retardation, depersonalization, or
paranoia); and [d] treatment (less use of
lithium or
antipsychotics, more
antidepressant and
benzodiazepine treatment).
CONCLUSIONS: BD-2 was characterized by more prominent and longer depressions with some
hypomania and mixed-features but not
mania and rarely
psychosis. BD-2 subjects had higher socioeconomic and functional status but also high levels of long-term morbidity and suicidal risk. Accordingly, BD-2 is dissimilar to, but not necessarily less severe than BD-1, consistent with being distinct syndromes.